4 Matching Annotations
  1. Nov 2022
    1. Neither the developmental nor the validation datasetsincluded patients with mild (GOLD 1) severity and, assuch, we could not establish the accuracy of predictionsfor this subgroup.

      Mencionar en nuestros estudios

    2. ACCEPT is externally validated in anindependent cohort extending its generalisability beyondtherapeutic clinical trials.

      Esto es algo que podríamos hacer en el CSA2

    3. Azithromycin reduces annual exacer-bation rate by 27%.8


    4. ACCEPT can combine predicted risk with effectestimates from randomised trials to enable personalisedtreatment.

      esto sería interesante recalcar en el ensayo clínico